Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-10,000
Closed -$560K 683
2016
Q3
$560K Buy
+10,000
New +$54.9K 0.08% 147
2016
Q2
Sell
-15,000
Closed -$453K 631
2016
Q1
$453K Buy
+15,000
New +$46.6K 0.06% 143
2015
Q4
Sell
-1,950
Closed -$3.9K 566
2015
Q3
$3.9K Sell
1,950
-12,000
-86% -$61.3K ﹤0.01% 386
2015
Q2
$298K Buy
+13,950
New +$93.4K 0.03% 180
2015
Q1
Sell
-1,000
Closed -$1K 560
2014
Q4
$1K Buy
+1,000
New +$9.36K ﹤0.01% 477

Other funds holding VALE

Exane Derivatives's VALE Position: Q2 2022 in Review

Exane Derivatives sold out of Vale (VALE) in Q2 2022, closing a stake of 117,076 shares — an estimated $2.34M sold.

Exane Derivatives first reported a position in VALE in Q1 2015 and held it in 19 quarters. The position peaked at $11M in Q1 2017. 484 funds tracked by Wall St. Rank hold VALE as of Q2 2022.

  • Exane Derivatives reported no remaining Vale position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 117,076 Vale shares in Q2 2022, an estimated $2.34M.
  • Exane Derivatives first reported a position in Vale in Q1 2015 and held it in 19 quarters.
  • Exane Derivatives's Vale position peaked at $11M in Q1 2017.
  • 484 funds tracked by Wall St. Rank held Vale as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.